Shri Ahimsa Naturals Ltd
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]
- Market Cap ₹ 528 Cr.
- Current Price ₹ 226
- High / Low ₹ 240 / 126
- Stock P/E 24.1
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 24.2 %
- ROE 18.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Promoter holding has decreased over last quarter: -25.6%
- Debtor days have increased from 62.9 to 96.2 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 104 | 78 | 96 | |
| 54 | 51 | 65 | |
| Operating Profit | 50 | 27 | 30 |
| OPM % | 48% | 34% | 32% |
| 2 | 1 | 2 | |
| Interest | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 |
| Profit before tax | 51 | 25 | 30 |
| Tax % | 25% | 26% | 26% |
| 38 | 19 | 22 | |
| EPS in Rs | 72.99 | 10.19 | 9.39 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 5 | 18 | 23 |
| Reserves | 60 | 66 | 131 |
| 3 | 14 | 0 | |
| 5 | 5 | 38 | |
| Total Liabilities | 74 | 103 | 193 |
| 28 | 40 | 47 | |
| CWIP | 4 | 8 | 4 |
| Investments | 0 | 0 | 0 |
| 42 | 56 | 142 | |
| Total Assets | 74 | 103 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 20 | 6 | 44 | |
| -10 | -17 | -4 | |
| -4 | 10 | 34 | |
| Net Cash Flow | 7 | -2 | 74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 39 | 53 | 96 |
| Inventory Days | 122 | 340 | 214 |
| Days Payable | 8 | 18 | 3 |
| Cash Conversion Cycle | 154 | 375 | 308 |
| Working Capital Days | 79 | 131 | 91 |
| ROCE % | 31% | 24% |
Documents
Announcements
-
Copy of Newspaper Publication
7 September 2025 - Notice published for 35th AGM and remote e-voting on Sep 07, 2025.
-
Shareholders meeting
6 September 2025 - 35th AGM notice; AGM Sept 30, 2025; FY25 revenue ₹9,580.61L, PAT ₹2,196.59L; ₹61 Cr plant.
-
Outcome of Board Meeting
3 September 2025 - Approved ₹35,00,00,000 subscription to subsidiary OCRPS; promoter share transfers; AGM on Sep 30, 2025; director reappointments.
-
Investor Presentation
25 August 2025 - Analyst/investor meeting on 24 Aug 2025; presentation shared; IPO completed; FY25 financial highlights and expansion plans.
-
Analysts/Institutional Investor Meet/Con. Call Updates
14 August 2025 - Shri Ahimsa Naturals to participate in Alpha Ideas SME Stars 2025 investor conference on August 24, 2025.
Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.